Aus dem Zentrum für Augenheilkunde der Universität zu Köln Klinik und Poliklinik für Allgemeine Augenheilkunde Geschäftsfü
![PDF) Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: Outcome of an expert roundtable PDF) Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: Outcome of an expert roundtable](https://i1.rgstatic.net/publication/51451258_Consensus_statement_on_indications_for_anti-angiogenic_therapy_in_the_management_of_corneal_diseases_associated_with_neovascularisation_Outcome_of_an_expert_roundtable/links/54ccad600cf298d6565aaacc/largepreview.png)
PDF) Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: Outcome of an expert roundtable
![Gebrauchsinformation: Information für Anwender. Avastin 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung Bevacizumab - PDF Kostenfreier Download Gebrauchsinformation: Information für Anwender. Avastin 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung Bevacizumab - PDF Kostenfreier Download](https://docplayer.org/docs-images/49/19252021/images/page_1.jpg)